White House unveils ‘bold goals’ for US biomanufacturing efforts
The US government is setting more goals around biomanufacturing efforts, with a vision for stronger supply chains and greater domestic production.
A 64-page report released by The White House on Thursday lays out “bold goals,” including an aim to produce at least a quarter of all active pharmaceutical ingredients in the US for small-molecule drugs within five years. While some of the report is centered around climate change and agricultural initiatives, it also presents goals for health and supply chain resilience.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters